BOTANIX PHARMACEUTICALS LTD - Announcements

3.23%

15.0¢

Market Cap $294.1M

Healthcare Biotechnology

Botanix (ASX:BOT) is an ASX-listed dermatology company based in Philadelphia and Phoenix... Botanix (ASX:BOT) is an ASX-listed dermatology company based in Philadelphia and Phoenix (USA), committed to the development of novel treatments for common skin diseases and infections.More

ASX:AFP

Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals (ASX:AFP). With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for stocks in the sector with room to run. Latest:...

Announcements

Filter Results

All Price Sensitive Only

BOT	Director Temporary Leave of Absence		23/08/19	197.65KB	Share
BOT	Appendix 4G		20/08/19	181.67KB	Share
BOT	Appendix 4E and Annual Report	PRICE SENSITIVE	20/08/19	1022.01KB	Share
BOT	Change in substantial holding		09/08/19	95.69KB	Share
BOT	Change in substantial holding		09/08/19	588.29KB	Share
BOT	Completion of Placement		09/08/19	168.48KB	Share
BOT	Appendix 3B and Notice Under Section 708A		09/08/19	374.14KB	Share
BOT	Placement Update		07/08/19	186.99KB	Share
BOT	Appendix 3B and Notice Under Section 708A		07/08/19	374.59KB	Share
BOT	Botanix $40 Million US Lead Placement and Management Update	PRICE SENSITIVE	01/08/19	193.2KB	Share
BOT	Appendix 4C - Quarterly	PRICE SENSITIVE	31/07/19	397.02KB	Share
BOT	Trading Halt	PRICE SENSITIVE	30/07/19	360.81KB	Share
BOT	Initial Director's Interest Notice		23/07/19	133.92KB	Share
BOT	Change of Director's Interest Notice MT		23/07/19	342.13KB	Share
BOT	Appendix 3B		18/07/19	285.61KB	Share
BOT	Vince Ippolito appointed as Botanix Executive Chairman		18/07/19	152.65KB	Share
BOT	Results of Meeting		18/07/19	462.52KB	Share
BOT	Exercise Price of Options		18/07/19	147.06KB	Share
BOT	Botanix Antimicrobial Platform Addresses Global Threat	PRICE SENSITIVE	15/07/19	271.04KB	Share
BOT	Appendix 3B		28/06/19	285.27KB	Share
BOT	Media Interview with Botanix President		27/06/19	187.69KB	Share
BOT	New BTX 1801 Data Presented at ASM Microbe 2019		24/06/19	198.9KB	Share
BOT	Updated Investor Presentation with New BTX 1801 Data		20/06/19	2.04MB	Share
BOT	BTX 1801 Kills Superbugs Without Resistance World-First	PRICE SENSITIVE	20/06/19	229.76KB	Share
BOT	Study Confirms Anti-inflammatory and Other Properties of CBD	PRICE SENSITIVE	19/06/19	866.27KB	Share
BOT	Trading Halt	PRICE SENSITIVE	18/06/19	242.68KB	Share
BOT	Pause in Trade	PRICE SENSITIVE	18/06/19	118.21KB	Share
BOT	Notice of General Meeting/Proxy Form		17/06/19	1005.44KB	Share
BOT	Appendix 3B		17/06/19	285.67KB	Share
BOT	Advisory Board Presentation on Psoriasis Market Opportunity		14/06/19	1.62MB	Share
BOT	Appendix 3B Amended		13/06/19	285.8KB	Share
BOT	Appendix 3B		13/06/19	285.42KB	Share
BOT	Botanix at the Jefferies Healthcare Conference		06/06/19	2.12MB	Share
BOT	Appendix 3B		31/05/19	285.32KB	Share
BOT	Appendix 3B		20/05/19	285.53KB	Share
BOT	Dermatology Industry Leader Joins Botanix	PRICE SENSITIVE	20/05/19	504.05KB	Share
BOT	Botanix Provides Retraction in Presentation	PRICE SENSITIVE	16/05/19	470.8KB	Share
BOT	Trading Halt	PRICE SENSITIVE	16/05/19	242.55KB	Share
BOT	Pause In Trading	PRICE SENSITIVE	16/05/19	117.85KB	Share
BOT	Botanix Presenting at Canaccord Genuity Cannabis Conference		14/05/19	1.52MB	Share
BOT	Appendix 4C - Quarterly	PRICE SENSITIVE	30/04/19	375.19KB	Share
BOT	Appendix 3B		18/04/19	285.68KB	Share
BOT	Appendix 3B and Notice Under Section 708A		18/03/19	300.59KB	Share
BOT	Details of Company Address		13/03/19	121.94KB	Share
BOT	Updated Investor Presentation		04/03/19	1.64MB	Share
BOT	Opinion Leaders Present Botanix Data at AAD 2019		04/03/19	481.6KB	Share
BOT	Appendix 3B		28/02/19	284.24KB	Share
BOT	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/19	390.01KB	Share
BOT	Permetrex Outperforms Other CBD Topical Products	PRICE SENSITIVE	26/02/19	8.72MB	Share
BOT	Change of Director's Interest Notice SW		26/02/19	216.01KB	Share
BOT	Appendix 3B		22/02/19	284.69KB	Share
BOT	Initial Director's Interest Notice SW		21/02/19	310.55KB	Share
BOT	Appointment of Non-Executive Chairman Dr Stewart Washer		21/02/19	466.17KB	Share
BOT	Initial Director's Interest Notice MT		15/02/19	134.1KB	Share
BOT	Appointment of Executive Director Dr Michael Thurn		12/02/19	125.39KB	Share
BOT	Final Director's Interest Notice		11/02/19	202.53KB	Share
BOT	Passing of Non-Executive Chairman Mr Graham Griffiths		08/02/19	114.1KB	Share
BOT	2019 Outlook Presentation		31/01/19	2.54MB	Share
BOT	Appendix 4C - Quarterly	PRICE SENSITIVE	31/01/19	839.2KB	Share
BOT	Investigators Meeting Completed for BTX 1204 Phase 2 Study	PRICE SENSITIVE	25/01/19	178.7KB	Share
BOT	Ethics Approval for Phase 2 Atopic Dermatitis Study Received	PRICE SENSITIVE	18/12/18	177.02KB	Share
BOT	Botanix Presents at International Cannabinoid Summit		14/12/18	8.3MB	Share
BOT	Appendix 3B		06/12/18	283.16KB	Share
BOT	Investor Presentation		05/12/18	2.13MB	Share
BOT	Botanix receives A$4.6m R&D Tax Incentive refund	PRICE SENSITIVE	23/11/18	151.28KB	Share
BOT	Results of Meeting		19/11/18	127.18KB	Share
BOT	Annual General Meeting Chairmans Address		19/11/18	140.02KB	Share
BOT	Investor Presentation		15/11/18	2.17MB	Share
BOT	First Patient Treated in BTX 1308 Psoriasis Patient Study	PRICE SENSITIVE	07/11/18	197.52KB	Share
BOT	Appendix 4C - Quarterly	PRICE SENSITIVE	31/10/18	350.81KB	Share
BOT	Notice of Annual General Meeting/Proxy Form		19/10/18	949.43KB	Share
BOT	Botanix Presents at Fall Clinical Dermatology Conference		19/10/18	1.01MB	Share
BOT	Ethics Approval for BTX 1308 Psoriasis Patient Study Secured	PRICE SENSITIVE	27/09/18	106.68KB	Share
BOT	Appendix 4G		21/09/18	111.29KB	Share
BOT	Annual Report to shareholders		21/09/18	686.81KB	Share
BOT	Botanix presents at European Dermatology Conference		13/09/18	1.16MB	Share
BOT	Botanix BTX 1503 Clinical Trial Update	PRICE SENSITIVE	12/09/18	151.01KB	Share
BOT	Pause in trading	PRICE SENSITIVE	12/09/18	117.1KB	Share
BOT	Preliminary Final Report	PRICE SENSITIVE	31/08/18	258.87KB	Share
BOT	FDA Clears Development Path for BTX 1204	PRICE SENSITIVE	30/08/18	131.96KB	Share
BOT	Updated Investor Presentation Revised		13/08/18	1.05MB	Share
BOT	Updated Investor Presentation		13/08/18	1.02MB	Share
BOT	Appendix 4C - Quarterly	PRICE SENSITIVE	31/07/18	590.1KB	Share
BOT	Botanix Expands Clinical Capabilities		27/07/18	107.97KB	Share
BOT	Investigators Meeting Completed for BTX 1503 Phase 2 Trial	PRICE SENSITIVE	23/07/18	111.27KB	Share
BOT	Botanix Joins with UQ to Accelerate Development of BTX 1801	PRICE SENSITIVE	19/07/18	207.21KB	Share
BOT	Appendix 3B		16/07/18	111.67KB	Share
BOT	Botanix update on development pipeline products	PRICE SENSITIVE	02/07/18	937.48KB	Share
BOT	Release of Securities from Escrow		29/06/18	87.82KB	Share
BOT	Change in substantial holding		27/06/18	594.44KB	Share
BOT	Change in substantial holding		27/06/18	45.99KB	Share
BOT	Completion of Placement		27/06/18	143.12KB	Share
BOT	Appendix 3B and Notice Under Section 708A		27/06/18	222.55KB	Share
BOT	First Patients Recruited into BTX 1503 Phase 2 Acne Trial	PRICE SENSITIVE	27/06/18	110.99KB	Share
BOT	BOT Welcomes First FDA Approval for Cannabidiol Product	PRICE SENSITIVE	26/06/18	139.87KB	Share
BOT	Botanix Raises A$8m in Oversubscribed Placement	PRICE SENSITIVE	20/06/18	110.13KB	Share
BOT	Trading Halt	PRICE SENSITIVE	18/06/18	434.33KB	Share
BOT	Australian Ethics approval for Acne Study	PRICE SENSITIVE	13/06/18	107.55KB	Share
BOT	Investor Presentation		12/06/18	1.07MB	Share
BOT	BTX 1204 Atopic Dermatitis Study Results Presentation	PRICE SENSITIVE	07/06/18	804.09KB	Share

BOT Director Temporary Leave of Absence
23/08/19		197.65KB	Share
BOT Appendix 4G
20/08/19		181.67KB	Share
BOT Appendix 4E and Annual Report
20/08/19	PRICE SENSITIVE	1022.01KB	Share
BOT Change in substantial holding
09/08/19		95.69KB	Share
BOT Change in substantial holding
09/08/19		588.29KB	Share
BOT Completion of Placement
09/08/19		168.48KB	Share
BOT Appendix 3B and Notice Under Section 708A
09/08/19		374.14KB	Share
BOT Placement Update
07/08/19		186.99KB	Share
BOT Appendix 3B and Notice Under Section 708A
07/08/19		374.59KB	Share
BOT Botanix $40 Million US Lead Placement and Management Update
01/08/19	PRICE SENSITIVE	193.2KB	Share
BOT Appendix 4C - Quarterly
31/07/19	PRICE SENSITIVE	397.02KB	Share
BOT Trading Halt
30/07/19	PRICE SENSITIVE	360.81KB	Share
BOT Initial Director's Interest Notice
23/07/19		133.92KB	Share
BOT Change of Director's Interest Notice MT
23/07/19		342.13KB	Share
BOT Appendix 3B
18/07/19		285.61KB	Share
BOT Vince Ippolito appointed as Botanix Executive Chairman
18/07/19		152.65KB	Share
BOT Results of Meeting
18/07/19		462.52KB	Share
BOT Exercise Price of Options
18/07/19		147.06KB	Share
BOT Botanix Antimicrobial Platform Addresses Global Threat
15/07/19	PRICE SENSITIVE	271.04KB	Share
BOT Appendix 3B
28/06/19		285.27KB	Share
BOT Media Interview with Botanix President
27/06/19		187.69KB	Share
BOT New BTX 1801 Data Presented at ASM Microbe 2019
24/06/19		198.9KB	Share
BOT Updated Investor Presentation with New BTX 1801 Data
20/06/19		2.04MB	Share
BOT BTX 1801 Kills Superbugs Without Resistance World-First
20/06/19	PRICE SENSITIVE	229.76KB	Share
BOT Study Confirms Anti-inflammatory and Other Properties of CBD
19/06/19	PRICE SENSITIVE	866.27KB	Share
BOT Trading Halt
18/06/19	PRICE SENSITIVE	242.68KB	Share
BOT Pause in Trade
18/06/19	PRICE SENSITIVE	118.21KB	Share
BOT Notice of General Meeting/Proxy Form
17/06/19		1005.44KB	Share
BOT Appendix 3B
17/06/19		285.67KB	Share
BOT Advisory Board Presentation on Psoriasis Market Opportunity
14/06/19		1.62MB	Share
BOT Appendix 3B Amended
13/06/19		285.8KB	Share
BOT Appendix 3B
13/06/19		285.42KB	Share
BOT Botanix at the Jefferies Healthcare Conference
06/06/19		2.12MB	Share
BOT Appendix 3B
31/05/19		285.32KB	Share
BOT Appendix 3B
20/05/19		285.53KB	Share
BOT Dermatology Industry Leader Joins Botanix
20/05/19	PRICE SENSITIVE	504.05KB	Share
BOT Botanix Provides Retraction in Presentation
16/05/19	PRICE SENSITIVE	470.8KB	Share
BOT Trading Halt
16/05/19	PRICE SENSITIVE	242.55KB	Share
BOT Pause In Trading
16/05/19	PRICE SENSITIVE	117.85KB	Share
BOT Botanix Presenting at Canaccord Genuity Cannabis Conference
14/05/19		1.52MB	Share
BOT Appendix 4C - Quarterly
30/04/19	PRICE SENSITIVE	375.19KB	Share
BOT Appendix 3B
18/04/19		285.68KB	Share
BOT Appendix 3B and Notice Under Section 708A
18/03/19		300.59KB	Share
BOT Details of Company Address
13/03/19		121.94KB	Share
BOT Updated Investor Presentation
04/03/19		1.64MB	Share
BOT Opinion Leaders Present Botanix Data at AAD 2019
04/03/19		481.6KB	Share
BOT Appendix 3B
28/02/19		284.24KB	Share
BOT Half Yearly Report and Accounts
28/02/19	PRICE SENSITIVE	390.01KB	Share
BOT Permetrex Outperforms Other CBD Topical Products
26/02/19	PRICE SENSITIVE	8.72MB	Share
BOT Change of Director's Interest Notice SW
26/02/19		216.01KB	Share
BOT Appendix 3B
22/02/19		284.69KB	Share
BOT Initial Director's Interest Notice SW
21/02/19		310.55KB	Share
BOT Appointment of Non-Executive Chairman Dr Stewart Washer
21/02/19		466.17KB	Share
BOT Initial Director's Interest Notice MT
15/02/19		134.1KB	Share
BOT Appointment of Executive Director Dr Michael Thurn
12/02/19		125.39KB	Share
BOT Final Director's Interest Notice
11/02/19		202.53KB	Share
BOT Passing of Non-Executive Chairman Mr Graham Griffiths
08/02/19		114.1KB	Share
BOT 2019 Outlook Presentation
31/01/19		2.54MB	Share
BOT Appendix 4C - Quarterly
31/01/19	PRICE SENSITIVE	839.2KB	Share
BOT Investigators Meeting Completed for BTX 1204 Phase 2 Study
25/01/19	PRICE SENSITIVE	178.7KB	Share
BOT Ethics Approval for Phase 2 Atopic Dermatitis Study Received
18/12/18	PRICE SENSITIVE	177.02KB	Share
BOT Botanix Presents at International Cannabinoid Summit
14/12/18		8.3MB	Share
BOT Appendix 3B
06/12/18		283.16KB	Share
BOT Investor Presentation
05/12/18		2.13MB	Share
BOT Botanix receives A$4.6m R&D Tax Incentive refund
23/11/18	PRICE SENSITIVE	151.28KB	Share
BOT Results of Meeting
19/11/18		127.18KB	Share
BOT Annual General Meeting Chairmans Address
19/11/18		140.02KB	Share
BOT Investor Presentation
15/11/18		2.17MB	Share
BOT First Patient Treated in BTX 1308 Psoriasis Patient Study
07/11/18	PRICE SENSITIVE	197.52KB	Share
BOT Appendix 4C - Quarterly
31/10/18	PRICE SENSITIVE	350.81KB	Share
BOT Notice of Annual General Meeting/Proxy Form
19/10/18		949.43KB	Share
BOT Botanix Presents at Fall Clinical Dermatology Conference
19/10/18		1.01MB	Share
BOT Ethics Approval for BTX 1308 Psoriasis Patient Study Secured
27/09/18	PRICE SENSITIVE	106.68KB	Share
BOT Appendix 4G
21/09/18		111.29KB	Share
BOT Annual Report to shareholders
21/09/18		686.81KB	Share
BOT Botanix presents at European Dermatology Conference
13/09/18		1.16MB	Share
BOT Botanix BTX 1503 Clinical Trial Update
12/09/18	PRICE SENSITIVE	151.01KB	Share
BOT Pause in trading
12/09/18	PRICE SENSITIVE	117.1KB	Share
BOT Preliminary Final Report
31/08/18	PRICE SENSITIVE	258.87KB	Share
BOT FDA Clears Development Path for BTX 1204
30/08/18	PRICE SENSITIVE	131.96KB	Share
BOT Updated Investor Presentation Revised
13/08/18		1.05MB	Share
BOT Updated Investor Presentation
13/08/18		1.02MB	Share
BOT Appendix 4C - Quarterly
31/07/18	PRICE SENSITIVE	590.1KB	Share
BOT Botanix Expands Clinical Capabilities
27/07/18		107.97KB	Share
BOT Investigators Meeting Completed for BTX 1503 Phase 2 Trial
23/07/18	PRICE SENSITIVE	111.27KB	Share
BOT Botanix Joins with UQ to Accelerate Development of BTX 1801
19/07/18	PRICE SENSITIVE	207.21KB	Share
BOT Appendix 3B
16/07/18		111.67KB	Share
BOT Botanix update on development pipeline products
02/07/18	PRICE SENSITIVE	937.48KB	Share
BOT Release of Securities from Escrow
29/06/18		87.82KB	Share
BOT Change in substantial holding
27/06/18		594.44KB	Share
BOT Change in substantial holding
27/06/18		45.99KB	Share
BOT Completion of Placement
27/06/18		143.12KB	Share
BOT Appendix 3B and Notice Under Section 708A
27/06/18		222.55KB	Share
BOT First Patients Recruited into BTX 1503 Phase 2 Acne Trial
27/06/18	PRICE SENSITIVE	110.99KB	Share
BOT BOT Welcomes First FDA Approval for Cannabidiol Product
26/06/18	PRICE SENSITIVE	139.87KB	Share
BOT Botanix Raises A$8m in Oversubscribed Placement
20/06/18	PRICE SENSITIVE	110.13KB	Share
BOT Trading Halt
18/06/18	PRICE SENSITIVE	434.33KB	Share
BOT Australian Ethics approval for Acne Study
13/06/18	PRICE SENSITIVE	107.55KB	Share
BOT Investor Presentation
12/06/18		1.07MB	Share
BOT BTX 1204 Atopic Dermatitis Study Results Presentation
07/06/18	PRICE SENSITIVE	804.09KB	Share

REFRESH

First 3 4 5 6 7

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 15.0¢		Change -0.005(3.23%)		Mkt cap ! $294.1M

Open	High	Low	Value	Volume
15.5¢	15.5¢	14.5¢	$1.946M	12.95M

Buyers (Bids)

No.	Vol.	Price($)
25	1287682	15.0¢

Sellers (Offers)

Price($)	Vol.	No.
15.5¢	2455412	18

View Market Depth

No.	Vol.	Price($)
24	1154349	0.150
44	3516891	0.145
100	3905887	0.140
50	1471240	0.135
67	10864858	0.130

Price($)	Vol.	No.
0.155	2445412	17
0.160	1542748	22
0.165	800166	15
0.170	1755173	31
0.175	1981476	22

Last trade - 16.10pm 31/07/2025 (20 minute delay)

BOT (ASX) Chart

BOTANIX PHARMACEUTICALS LTD - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

Top Stories